The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Testosterone Hormone Drug Market Research Report 2025
Synopsis
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
The global Testosterone Hormone Drug market was valued at US$ 1460 million in 2023 and is anticipated to reach US$ 1274.1 million by 2030, witnessing a CAGR of -1.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Testosterone Hormone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Hormone Drug.
Report Scope
The Testosterone Hormone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Hormone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Hormone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Viatris
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Segment by Type
Gels
Injections
Patches
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Hormone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Hormone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
The global Testosterone Hormone Drug market was valued at US$ 1460 million in 2023 and is anticipated to reach US$ 1274.1 million by 2030, witnessing a CAGR of -1.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Testosterone Hormone Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Hormone Drug.
Report Scope
The Testosterone Hormone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Hormone Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Hormone Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Viatris
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Segment by Type
Gels
Injections
Patches
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Hormone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Hormone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Testosterone Hormone Drug Market Overview
1.1 Product Overview and Scope of Testosterone Hormone Drug
1.2 Testosterone Hormone Drug Segment by Type
1.2.1 Global Testosterone Hormone Drug Market Value Comparison by Type (2024-2030)
1.2.2 Gels
1.2.3 Injections
1.2.4 Patches
1.3 Testosterone Hormone Drug Segment by Application
1.3.1 Global Testosterone Hormone Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Testosterone Hormone Drug Market Size Estimates and Forecasts
1.4.1 Global Testosterone Hormone Drug Revenue 2019-2030
1.4.2 Global Testosterone Hormone Drug Sales 2019-2030
1.4.3 Global Testosterone Hormone Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Testosterone Hormone Drug Market Competition by Manufacturers
2.1 Global Testosterone Hormone Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Testosterone Hormone Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Testosterone Hormone Drug Average Price by Manufacturers (2019-2024)
2.4 Global Testosterone Hormone Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Hormone Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Hormone Drug, Product Type & Application
2.7 Testosterone Hormone Drug Market Competitive Situation and Trends
2.7.1 Testosterone Hormone Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Testosterone Hormone Drug Players Market Share by Revenue
2.7.3 Global Testosterone Hormone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Testosterone Hormone Drug Retrospective Market Scenario by Region
3.1 Global Testosterone Hormone Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Testosterone Hormone Drug Global Testosterone Hormone Drug Sales by Region: 2019-2030
3.2.1 Global Testosterone Hormone Drug Sales by Region: 2019-2024
3.2.2 Global Testosterone Hormone Drug Sales by Region: 2025-2030
3.3 Global Testosterone Hormone Drug Global Testosterone Hormone Drug Revenue by Region: 2019-2030
3.3.1 Global Testosterone Hormone Drug Revenue by Region: 2019-2024
3.3.2 Global Testosterone Hormone Drug Revenue by Region: 2025-2030
3.4 North America Testosterone Hormone Drug Market Facts & Figures by Country
3.4.1 North America Testosterone Hormone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Testosterone Hormone Drug Sales by Country (2019-2030)
3.4.3 North America Testosterone Hormone Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Testosterone Hormone Drug Market Facts & Figures by Country
3.5.1 Europe Testosterone Hormone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Testosterone Hormone Drug Sales by Country (2019-2030)
3.5.3 Europe Testosterone Hormone Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Hormone Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Testosterone Hormone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Testosterone Hormone Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Testosterone Hormone Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Testosterone Hormone Drug Market Facts & Figures by Country
3.7.1 Latin America Testosterone Hormone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Testosterone Hormone Drug Sales by Country (2019-2030)
3.7.3 Latin America Testosterone Hormone Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Hormone Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Hormone Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Testosterone Hormone Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Testosterone Hormone Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Hormone Drug Sales by Type (2019-2030)
4.1.1 Global Testosterone Hormone Drug Sales by Type (2019-2024)
4.1.2 Global Testosterone Hormone Drug Sales by Type (2025-2030)
4.1.3 Global Testosterone Hormone Drug Sales Market Share by Type (2019-2030)
4.2 Global Testosterone Hormone Drug Revenue by Type (2019-2030)
4.2.1 Global Testosterone Hormone Drug Revenue by Type (2019-2024)
4.2.2 Global Testosterone Hormone Drug Revenue by Type (2025-2030)
4.2.3 Global Testosterone Hormone Drug Revenue Market Share by Type (2019-2030)
4.3 Global Testosterone Hormone Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Testosterone Hormone Drug Sales by Application (2019-2030)
5.1.1 Global Testosterone Hormone Drug Sales by Application (2019-2024)
5.1.2 Global Testosterone Hormone Drug Sales by Application (2025-2030)
5.1.3 Global Testosterone Hormone Drug Sales Market Share by Application (2019-2030)
5.2 Global Testosterone Hormone Drug Revenue by Application (2019-2030)
5.2.1 Global Testosterone Hormone Drug Revenue by Application (2019-2024)
5.2.2 Global Testosterone Hormone Drug Revenue by Application (2025-2030)
5.2.3 Global Testosterone Hormone Drug Revenue Market Share by Application (2019-2030)
5.3 Global Testosterone Hormone Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Testosterone Hormone Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Endo International
6.2.1 Endo International Corporation Information
6.2.2 Endo International Description and Business Overview
6.2.3 Endo International Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Endo International Testosterone Hormone Drug Product Portfolio
6.2.5 Endo International Recent Developments/Updates
6.3 Eli lilly
6.3.1 Eli lilly Corporation Information
6.3.2 Eli lilly Description and Business Overview
6.3.3 Eli lilly Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli lilly Testosterone Hormone Drug Product Portfolio
6.3.5 Eli lilly Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Testosterone Hormone Drug Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Actavis (Allergan)
6.5.1 Actavis (Allergan) Corporation Information
6.5.2 Actavis (Allergan) Description and Business Overview
6.5.3 Actavis (Allergan) Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actavis (Allergan) Testosterone Hormone Drug Product Portfolio
6.5.5 Actavis (Allergan) Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Testosterone Hormone Drug Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Testosterone Hormone Drug Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Testosterone Hormone Drug Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Viatris
6.9.1 Viatris Corporation Information
6.9.2 Viatris Description and Business Overview
6.9.3 Viatris Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Viatris Testosterone Hormone Drug Product Portfolio
6.9.5 Viatris Recent Developments/Updates
6.10 Upsher-Smith
6.10.1 Upsher-Smith Corporation Information
6.10.2 Upsher-Smith Description and Business Overview
6.10.3 Upsher-Smith Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Upsher-Smith Testosterone Hormone Drug Product Portfolio
6.10.5 Upsher-Smith Recent Developments/Updates
6.11 Ferring Pharmaceuticals
6.11.1 Ferring Pharmaceuticals Corporation Information
6.11.2 Ferring Pharmaceuticals Testosterone Hormone Drug Description and Business Overview
6.11.3 Ferring Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ferring Pharmaceuticals Testosterone Hormone Drug Product Portfolio
6.11.5 Ferring Pharmaceuticals Recent Developments/Updates
6.12 Kyowa Kirin
6.12.1 Kyowa Kirin Corporation Information
6.12.2 Kyowa Kirin Testosterone Hormone Drug Description and Business Overview
6.12.3 Kyowa Kirin Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kyowa Kirin Testosterone Hormone Drug Product Portfolio
6.12.5 Kyowa Kirin Recent Developments/Updates
6.13 Acerus Pharmaceuticals
6.13.1 Acerus Pharmaceuticals Corporation Information
6.13.2 Acerus Pharmaceuticals Testosterone Hormone Drug Description and Business Overview
6.13.3 Acerus Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Acerus Pharmaceuticals Testosterone Hormone Drug Product Portfolio
6.13.5 Acerus Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Hormone Drug Industry Chain Analysis
7.2 Testosterone Hormone Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Hormone Drug Production Mode & Process
7.4 Testosterone Hormone Drug Sales and Marketing
7.4.1 Testosterone Hormone Drug Sales Channels
7.4.2 Testosterone Hormone Drug Distributors
7.5 Testosterone Hormone Drug Customers
8 Testosterone Hormone Drug Market Dynamics
8.1 Testosterone Hormone Drug Industry Trends
8.2 Testosterone Hormone Drug Market Drivers
8.3 Testosterone Hormone Drug Market Challenges
8.4 Testosterone Hormone Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Testosterone Hormone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Testosterone Hormone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Testosterone Hormone Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Testosterone Hormone Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Testosterone Hormone Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Testosterone Hormone Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Testosterone Hormone Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Testosterone Hormone Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Testosterone Hormone Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Testosterone Hormone Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Testosterone Hormone Drug, Product Type & Application
Table 12. Global Key Manufacturers of Testosterone Hormone Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Testosterone Hormone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Hormone Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Testosterone Hormone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Testosterone Hormone Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Testosterone Hormone Drug Sales Market Share by Region (2019-2024)
Table 19. Global Testosterone Hormone Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Testosterone Hormone Drug Sales Market Share by Region (2025-2030)
Table 21. Global Testosterone Hormone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Testosterone Hormone Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Testosterone Hormone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Testosterone Hormone Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Testosterone Hormone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Testosterone Hormone Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Testosterone Hormone Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Testosterone Hormone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Testosterone Hormone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Testosterone Hormone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Testosterone Hormone Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Testosterone Hormone Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Testosterone Hormone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Testosterone Hormone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Testosterone Hormone Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Testosterone Hormone Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Testosterone Hormone Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Testosterone Hormone Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Testosterone Hormone Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Testosterone Hormone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Testosterone Hormone Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Testosterone Hormone Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Testosterone Hormone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Testosterone Hormone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Testosterone Hormone Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Testosterone Hormone Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Testosterone Hormone Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Testosterone Hormone Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Testosterone Hormone Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Testosterone Hormone Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Testosterone Hormone Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Testosterone Hormone Drug Sales Market Share by Type (2019-2024)
Table 53. Global Testosterone Hormone Drug Sales Market Share by Type (2025-2030)
Table 54. Global Testosterone Hormone Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Testosterone Hormone Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Testosterone Hormone Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Testosterone Hormone Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Testosterone Hormone Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Testosterone Hormone Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Testosterone Hormone Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Testosterone Hormone Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Testosterone Hormone Drug Sales Market Share by Application (2019-2024)
Table 63. Global Testosterone Hormone Drug Sales Market Share by Application (2025-2030)
Table 64. Global Testosterone Hormone Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Testosterone Hormone Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Testosterone Hormone Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Testosterone Hormone Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Testosterone Hormone Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Testosterone Hormone Drug Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Testosterone Hormone Drug Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Endo International Corporation Information
Table 76. Endo International Description and Business Overview
Table 77. Endo International Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Endo International Testosterone Hormone Drug Product
Table 79. Endo International Recent Developments/Updates
Table 80. Eli lilly Corporation Information
Table 81. Eli lilly Description and Business Overview
Table 82. Eli lilly Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli lilly Testosterone Hormone Drug Product
Table 84. Eli lilly Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Testosterone Hormone Drug Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Actavis (Allergan) Corporation Information
Table 91. Actavis (Allergan) Description and Business Overview
Table 92. Actavis (Allergan) Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Actavis (Allergan) Testosterone Hormone Drug Product
Table 94. Actavis (Allergan) Recent Developments/Updates
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bayer Testosterone Hormone Drug Product
Table 99. Bayer Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novartis Testosterone Hormone Drug Product
Table 104. Novartis Recent Developments/Updates
Table 105. Teva Corporation Information
Table 106. Teva Description and Business Overview
Table 107. Teva Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Teva Testosterone Hormone Drug Product
Table 109. Teva Recent Developments/Updates
Table 110. Viatris Corporation Information
Table 111. Viatris Description and Business Overview
Table 112. Viatris Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Viatris Testosterone Hormone Drug Product
Table 114. Viatris Recent Developments/Updates
Table 115. Upsher-Smith Corporation Information
Table 116. Upsher-Smith Description and Business Overview
Table 117. Upsher-Smith Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Upsher-Smith Testosterone Hormone Drug Product
Table 119. Upsher-Smith Recent Developments/Updates
Table 120. Ferring Pharmaceuticals Corporation Information
Table 121. Ferring Pharmaceuticals Description and Business Overview
Table 122. Ferring Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ferring Pharmaceuticals Testosterone Hormone Drug Product
Table 124. Ferring Pharmaceuticals Recent Developments/Updates
Table 125. Kyowa Kirin Corporation Information
Table 126. Kyowa Kirin Description and Business Overview
Table 127. Kyowa Kirin Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Kyowa Kirin Testosterone Hormone Drug Product
Table 129. Kyowa Kirin Recent Developments/Updates
Table 130. Acerus Pharmaceuticals Corporation Information
Table 131. Acerus Pharmaceuticals Description and Business Overview
Table 132. Acerus Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Acerus Pharmaceuticals Testosterone Hormone Drug Product
Table 134. Acerus Pharmaceuticals Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Testosterone Hormone Drug Distributors List
Table 138. Testosterone Hormone Drug Customers List
Table 139. Testosterone Hormone Drug Market Trends
Table 140. Testosterone Hormone Drug Market Drivers
Table 141. Testosterone Hormone Drug Market Challenges
Table 142. Testosterone Hormone Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Testosterone Hormone Drug
Figure 2. Global Testosterone Hormone Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Testosterone Hormone Drug Market Share by Type in 2023 & 2030
Figure 4. Gels Product Picture
Figure 5. Injections Product Picture
Figure 6. Patches Product Picture
Figure 7. Global Testosterone Hormone Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Testosterone Hormone Drug Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Testosterone Hormone Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Testosterone Hormone Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Testosterone Hormone Drug Sales (2019-2030) & (K Units)
Figure 15. Global Testosterone Hormone Drug Average Price (US$/Unit) & (2019-2030)
Figure 16. Testosterone Hormone Drug Report Years Considered
Figure 17. Testosterone Hormone Drug Sales Share by Manufacturers in 2023
Figure 18. Global Testosterone Hormone Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Testosterone Hormone Drug Players: Market Share by Revenue in 2023
Figure 20. Testosterone Hormone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Testosterone Hormone Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Testosterone Hormone Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Testosterone Hormone Drug Revenue Market Share by Country (2019-2030)
Figure 24. United States Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Testosterone Hormone Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Testosterone Hormone Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Testosterone Hormone Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Testosterone Hormone Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Testosterone Hormone Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Testosterone Hormone Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Testosterone Hormone Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Testosterone Hormone Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Testosterone Hormone Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Testosterone Hormone Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Testosterone Hormone Drug by Type (2019-2030)
Figure 56. Global Testosterone Hormone Drug Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Testosterone Hormone Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Testosterone Hormone Drug by Application (2019-2030)
Figure 59. Global Testosterone Hormone Drug Price (US$/Unit) by Application (2019-2030)
Figure 60. Testosterone Hormone Drug Value Chain
Figure 61. Testosterone Hormone Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
